Formulations of jasmonates and nanocarriers or microcarriers
AssigneeNanocare Technologies, Inc.
InventorJosé Emilio Fehr Pereira Lopes
Life of this patent
Estimating the term…
Abstract
The present disclosure provides compositions comprising a jasmonic acid derivative and a carrier, such as a liposome or cyclodextrin. Said compositions may be used for treating cancer.
Claims13
A pharmaceutical formulation comprising an active principle selected from methyl jasmonate, jasmonic acid, 7-iso-jasmonic acid, 2,3-didehydrojasmonic acid, 3,4-didehydrojasmonic acid, 3,7-didehydrojasmonic acid, 4,5-didehydrojasmonic acid, 4,5-didehydro-7-isojasmonic acid, cucurbic acid, 6-epi-cucurbic acid, 6-epi-cucurbic acid-lactone, 12-hydroxy-jasmonic acid, 12-hydroxy-jasmonic acid-lactone, 11-hydroxy-jasmonic acid, 8-hydroxy-jasmonic acid, tuberonic acid, tuberonic acid-O-β-glucopyranoside, cucurbic acid-O-β-glucopyranoside, 5,6-didehydro-jasmonic acid, 6,7-didehydro-jasmonic acid, 7,8-didehydro-jasmonic acid and a lower alkyl ester thereof and a nanocarrier or microcarrier, wherein the active principle is included into, inside, associated with, conjugated with, and/or at the nanocarrier or microcarrier, and the nanocarrier or microcarrier comprises a liposome selected from a PEGylated liposome, poly(ethylene glycol)-600-hydroxystearate (PEG-HS), and LDE, the liposome being a unilamellar vesicle or a multilamellar vesicle, a dendrimer, linear bis poly(ethylene glycol) (PEG) polymer with branched spacers, a hyaluronan polymer, a peptide nanovesicle, a lipid nanotube, a cationic solid lipid microparticle, a gelatin nanoparticle, a polylactic glycolic acid nanoparticle, a hydrogel microparticle, chitosan, or a lipoglycoprotein, and further wherein the pharmaceutical formulation is in the form of an emulsion.
A cosmetic formulation comprising an active principle selected from methyl jasmonate, jasmonic acid, 7-iso-jasmonic acid, 2,3-didehydrojasmonic acid, 3,4-didehydrojasmonic acid, 3,7-didehydrojasmonic acid, 4,5-didehydrojasmonic acid, 4,5-didehydro-7-isojasmonic acid, cucurbic acid, 6-epi-cucurbic acid, 6-epi-cucurbic acid-lactone, 12-hydroxy-jasmonic acid, 12-hydroxy-jasmonic acid-lactone, 11-hydroxy-jasmonic acid, 8-hydroxy-jasmonic acid, tuberonic acid, tuberonic acid-O-β-glucopyranoside, cucurbic acid-O-β-glucopyranoside, 5,6-didehydro-jasmonic acid, 6,7-didehydro-jasmonic acid, 7,8-didehydro-jasmonic acid and a lower alkyl ester thereof, and a nanocarrier or microcarrier, wherein the active principle is included into, inside, associated with, conjugated with, and/or at the nanocarrier or microcarrier, and the nanocarrier or microcarrier comprises a liposome selected from a PEGylated liposome, poly(ethylene glycol)-600-hydroxystearate (PEG-HS), and LDE, the liposome being a unilamellar vesicle or a multilamellar vesicle, a dendrimer, linear bis poly(ethylene glycol) (PEG) polymer with branched spacers, a hyaluronan polymer, a peptide nanovesicle, a lipid nanotube, a cationic solid lipid microparticle, a gelatin nanoparticle, a polylactic glycolic acid nanoparticle, a hydrogel microparticle, or a lipoglycoprotein, and further wherein the cosmetic formulation is in the form of an emulsion.
Dependencies are inferred from the claim text.